Tech Company Financing Transactions
Strategikon Pharma Funding Round
Decathlon Capital Partners joined a funding round for Strategikon Pharma. The round was announced on 6/10/2025.
Transaction Overview
Company Name
Announced On
6/10/2025
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Decathlon Capital Partners (John Borchers)
Proceeds Purpose
The multi-million dollar investment package will be used to expand Strategikon's sales and client support teams to meet growing market demand for its innovative Clinical Maestro® platform.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1 Sansome St. 35th Floor 40621
San Francisco, CA 94104
USA
San Francisco, CA 94104
USA
Phone
Website
Email Address
Overview
Clinical Maestro, Strategikon's flagship product, is a cloud-based platform that modernizes outsourcing for clinical programs. It enables all participants in clinical trials, Sponsor Companies, Vendors and Service Providers, to plan studies, model and manage clinical contracts in an entirely systematic way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anca Copaescu
Chief Operating Officer
Paulo Carvalho
VP - Bus. Development
Farah Ahmad
VP - Bus. Development
Michael Quinn
VP - Bus. Development
Oren Sebag
VP - Customer Service
Sandy Imboden
VP - Marketing
Karen Wills
Browse more venture capital transactions:
Prev: 6/10/2025: Eli Health venture capital transaction
Next: 6/10/2025: VODA.ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs